Equity Profile
Post-Earnings Recap
AXSOME THERAPEUTICS
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.07 | $2.04 | +4.55% |
| Revenue | — | $1.4B | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Maximus, Inc. operates in the industrial sector, focusing on data processing and outsourced services....
EPS
Earnings per share is a key indicator of profitability and can influence investor sentiment.
Revenue
Revenue figures provide insight into the company's overall growth and market demand.
Wall Street expectations, options signals, track record, and call prep available with Pro.